Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.110220
Revised: July 3, 2025
Accepted: August 14, 2025
Published online: September 26, 2025
Processing time: 108 Days and 5.5 Hours
Peripheral endovascular intervention (PEVI) is performed using radiation. Radiation has deleterious health consequences for patients and operators.
To investigate the gender radiation disparities and procedural outcomes in PEVI.
A prospective observational study was performed in 186 consecutive patients (65 ± 12 years) at an academic medical center from January 2019 to April 2020 (mean follow-up of 3.9 ± 3.6 months) comparing the gender radiation disparity and outcomes of PEVI (n = 147 underwent intervention, 79.0%). Groups were divided into women (n = 99, 53.2%) and men (n = 87, 48.4%). Primary endpoints included air kerma, dose area product (DAP), fluoroscopy time, and contrast use. Secondary endpoints included all-cause mortality, acute myocardial infarction, acute kidney injury, stroke, repeat revascularization, major adverse limb event, and the composite of complications.
Men showed increased DAP compared with women (15221.2 ± 25858.5 µGy × m2vs 9251.7 ± 9555.3 µGy × m2, P = 0.047), but no significant difference in air kerma or any other primary endpoints. In the secondary endpoints, no significant diffe
Men had increased DAP indicating more radiation absorption in the exposed area. Gender outcomes showed no difference in complications. Thus, PEVI can be safely performed in men or women.
Core Tip: Radiation is harmful to patients and operators. During peripheral angiogram and peripheral endovascular intervention (PEVI), radiation is produced. Our study showed that men had a greater dose area product compared with women, but no difference in procedural outcomes. These findings are important, so that we may consider more radiation prudent practices in men to minimize the patient’s and operator’s radiation exposure. Such a study has not been previously conducted in PEVI and provides important real-world information.